尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Kandera Reinhard, 首席财务官. Insider active across 1 company, notably HOOKIPA Pharma Inc.. Aggregated, 4 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €20k. Activity tracked since 1 February 2022. The latest transaction was filed on 21 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Reinhard Kandera is the Chief Financial Officer at HOOKIPA Pharma Inc. He manages the financial aspects of the company, including financial planning and reporting. His role is crucial in ensuring HOOKIPA's financial health and supporting its research and development initiatives.